US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Vivesto AB (0N4A) 銘柄情報

Vivesto AB (0N4A)

5.2065

0.00

(0.00%)

終了 7月6日 12:30AM

Vivesto AB (0N4A) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

5.2065

( - )

買値

4.948

売値

5.465

出来高

0.00

0.00 日の範囲 0.00

5.2065 52 週間の範囲 5.2065

時価総額

前日終値

5.2065

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

SEK 53,615

発行済株式数

11,071,369

配当利回り

PER

-1.62

1 株当たり利益 (EPS)

-5.37

歳入

-

純利益

-32.69M

Vivesto AB develops, develops, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product, Paccal Vet, is a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma. The company also provides Apealea, an injecta... Vivesto AB develops, develops, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product, Paccal Vet, is a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma. The company also provides Apealea, an injectable formulation of paclitaxel for the treatment of various cancers. In addition, it develops Cantrixil, a drug candidate for the treatment of advanced cancer, and Docetaxel micellar for the treatment of prostate cancer. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was founded in 1988 and is headquartered in Solna, Sweden. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.vivesto.com

本社

Solna, Sweden

設立

1988

Vivesto AB is listed in the sector of the ロンドン証券取引所 with ticker 0N4A. The last closing price for Vivesto AB was SEK5.21. Over the last year, Vivesto AB shares have traded in a share price range of SEK 5.2065 to SEK 5.2065.

Vivesto AB currently has 11,071,369 shares in issue. The market capitalisation of Vivesto AB is SEK57.64 million. Vivesto AB has a price to earnings ratio (PE ratio) of -1.62.

Oasmia Pharmaceutical AB (publ)

Oasmia Pharmaceutical AB (publ) Interim report for the period May 2017 – January 2018 Commercial focus and lower cost base THIRD QUARTER...

Oasmia Pharmaceutical’s Docecal program achieves significant development milestone

Oasmia Pharmaceutical’s Docecal program achieves significant development milestone Oasmia Pharmaceutical AB announces that all patients have...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	5.2065	5.2065	5.2065	8962	5.2065	DE
52	0	0	5.2065	5.2065	5.2065	2895	5.2065	DE
156	0	0	5.2065	5.2065	5.2065	873	5.2065	DE
260	0	0	5.2065	5.2065	5.2065	2255	5.2065	DE

0N4A - Frequently Asked Questions (FAQ)

What is the current Vivesto AB share price?

The current share price of Vivesto AB is SEK 5.2065

How many Vivesto AB shares are in issue?

Vivesto AB has 11,071,369 shares in issue

What is the market cap of Vivesto AB?

The market capitalisation of Vivesto AB is SEK 57.64M

What is the 1 year trading range for Vivesto AB share price?

Vivesto AB has traded in the range of SEK 5.2065 to SEK 5.2065 during the past year

What is the PE ratio of Vivesto AB?

The price to earnings ratio of Vivesto AB is -1.62

What is the registered address of Vivesto AB?

The registered address for Vivesto AB is Gustav III:s Boulevard 46, Solna, Stockholm County, 169 73

What is the Vivesto AB website address?

The website address for Vivesto AB is www.vivesto.com

LOB

AI: As of July 2026, BLAQclouds Property Group has not yet provided a definitive date for when its shares will begin public trading. However, the spinout process from Blaqclouds Inc (OTCMKTS:BCDS) reached critical regulatory and administrative milestones in early 2026 that suggest it is in the final

WhenLambo

WhenLambo 6分前

FIFA communicated the partnership with VuMe themselves, that means we can be sure they did research about contractual agreements, licensing, the timeline, the benefits to FIFA such as revenue or engagement, the longterm goal alignment, etc

We know for sure that FIFA has not removed th

Tr8dervic

Tr8dervic 8分前

Powerball Winning Numbers for 7/4/2026

17 38 46 50 69 20
Power Play 2 X

There was no Grand Prize winner

The estimated Grand Prize was $402.7 Million ($180.7 Million Cash Value)

Next Powerball Drawing
Monday, Jul 06
Es

gitreal

gitreal 10分前

You wouldn't have a bunch of shares you were given, or given cheaply, would you?

That would be pretty unethical to ask investors to buy at the ask, when you are the one dumping, wouldn't it?

RRP60

I still see smitty here occasionally. But i miss ILT. He is no longer showing up. I dont know what happened to his vault.

Doc logic

Doc logic 13分前

Legend431,

Like FeMike said, a little pop then back unless there is other news. Not too many really thought DCVax -L didn’t work. This just helps with reimbursement, competitive advantage and eventual submissions to others including FDA. The question folks want answered is how NWBO

radly

July 1st now September 30th. SMH

ORCA

I DO NOT SEE ANYTHING HAPPENING THIS YEAR.AND ON TOP OF IT,THE SELLING OF INSIDERS AT .01 BLOCKS ANY MINI RUN THAT THIS THING COULD HAVE. IN THE NEAR FUTURE.POSSIBLY GOING LOWER THIS WEEK.MAYBE .008.BUYING AT .008 AND SELL AT .0098 TO KEEP INSIDERS FROM SELLING.

G_rokk

G_rokk 16分前

It’s about the tech to reach a tumor and kill it
Without the side effects of chemo or radiation
Or surgery To help people and save lives
I pray RDGL gets a chance to prove its worth and bury idiots
that root for its failure

ScottishTexan

ScottishTexan 18分前

And there’s no dd worth posting on the incoming company and leadership team. Youre just mad you’ve been fleeced again. You should be used to it by now.

ScottishTexan

ScottishTexan 19分前

The dilution is coming . How do you think they will make payroll ?

ORCA

$BCDS WILL BE TREMENDOUS IN AUGUST.UNTIL THEN WE LOAD EVERY DOWN DAY.JELLY BEAN SELLERS KEEP THEM COMING.EVERYTHING FALLS ON MY LAP ALMOST EVERY DAY.LOL.

tat4tat

tat4tat 22分前

Yeah, like getting new contracts with all of those South American companies.

rogers711

rogers711 27分前

Says the one that has held a penny stock for years and made 0 👍😂 congrats! Imagine what you could have done with the money tied up here doing nothing… many permabulls here have tied up massive liquidity in a micro penny stock and think they are great investors…

stockrafter

stockrafter 27分前

It is obvious from all the patent filings for drugs, and fancy new injectors they are setting Halozyme to produce a number of internal Drug-concentration-enhanze/AI combos......Do doubt about it.....could easily make a list of few......On the way to $100 and beyond. AR

CatfishHunter

CatfishHunter 30分前

I doubt you will, but if so, best of luck flipping $50 for a 25%-45% gain.

Eths

SNTX
https://x.com/ethsbythelake/status/2073898723017470310?s=46&t=6Y7w8L7iBETCgMYpIXWuzg

3331

Math concludes BIEL will be the GOAT!
BIEL hitting PPS .10 puts it in the conversation for the greatest stock ever - more than 100,000% appreciation from their all-time low.

Two companies currently compete for the absolute top spot in modern history: Apple and former penny sto

Frank69OH

Frank69OH 35分前

Hey_Its_That_Guy

Hey_Its_That_Guy 35分前

I don't see those numbers on my Schwab. But stuff like that does happen. Hopefully we'll have a good week

Legend431

Legend431 36分前

Doc - I’m not paid here despite all the posts. Nothing is going to happen. Hope you had a great 4th

santafe2

santafe2 36分前

Quiet Sunday night so I'm working through a few ideas. Comments pro or con always welcome. This is a complex, short term, economic period.

We have the birth of the AI age which will alter economies as much or more than any previous technical revolution. That's the long term change. I

Telefon

Telefon 42分前

What would be involved in removing the Rat as CEO? Would it need to be initiated by the board of directors? Could shareholders hold a meeting and demand his removal?

2.715% 12jul2029 2.715% ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。